According to Alembic Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 12.22%. At the end of 2023 the company had an Operating Margin of 6.45%.
Year | Operating Margin | Change |
---|---|---|
2023 | 6.45% | -46.06% |
2022 | 11.95% | -53.9% |
2021 | 25.93% | 16.49% |
2020 | 22.26% | 13.07% |
2019 | 19.68% | 10.38% |
2018 | 17.83% | 2.13% |
2017 | 17.46% | -43.37% |
2016 | 30.83% | 72.6% |
2015 | 17.86% | 4.68% |
2014 | 17.07% | 23.48% |
2013 | 13.82% | 22.99% |
2012 | 11.24% | 26.42% |
2011 | 8.89% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.